Ruesch Center | Georgetown University

Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.

Logo of the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center. This logo has four blue boxes and text.

Meet Ruesch Center Director:
John L. Marshall, MD

Connect With Us Via

Tweets by RueschCenter

Recent News

OncLive® and The Ruesch Center to Host the Second Annual Luminary Awards in GI Cancers
July 9, 2018
The awards honor individuals who are making a difference in the gastrointestinal cancers community.
A Potential Role for PARP Inhibitors in Pancreatic Cancer
July 5, 2018
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating Pancreatic Cancer patients with certain genetic mutations.
Experts Anticipate a Growing Menu of Frontline Options in Liver Cancer
July 4, 2018
Panelists review data for lenvatinib (Lenvima), and novel drugs under investigation in the second line for HCC, such as cabozantinib (Cabometyx/Cometriq) and pembrolizumab (Keytruda).
Marshall Makes the Case for Molecular Sorting in Gastrointestinal Disease
July 3, 2018
Oncologists have been slow to introduce targeted and immune therapies into the treatment of gastrointestinal cancers, but that is changing, and poor patient survival statistics call for a continuation of this trend.
How Microsatellite Instability Works in Colorectal Cancer
July 2, 2018
Understanding one’s biomarkers, such as microsatellite stable (MSS) or instable (MSI) status in tumors, is key in understanding how a patient with colorectal cancer may be treated.
Not All Pancreatic Cancers are the Same: Some Have Treatable Mutations
July 2, 2018
There are subgroups of patients with pancreatic cancer whose tumors are particularly susceptible to certain therapies.
Helping Caregivers: Advice, Support and More
June 28, 2018
At the GI Cancer Patient Summit, a panel of caregivers drew upon personal experience to offer advice and discuss what more can be done for individuals in this role of the cancer journey.
Advancing Care Across the Spectrum of Pancreatic Cancer
June 26, 2018
How are recent advances in treatment of pancreatic cancer affecting patient outcomes?